Alameda-based Celera Corp., a maker of genetic tests, was purchased by New Jersey-based Quest Diagnostics Inc. in a deal valued at $344 million.
Quest will pay $8 per share of Celera, which reported revenue of $128 million in 2010.
Celera executives said the company had been looking for a partner for sometime to help market and sell its testing products.
No comments:
Post a Comment